Search hospitals > Washington > Seattle
Seattle Children's Hospital
Claim this profileSeattle, Washington 98105
Global Leader in Leukemia
Global Leader in Brain Tumor
Conducts research for Tumors
Conducts research for Neuroblastoma
Conducts research for Recurrence
1025 reported clinical trials
77 medical researchers
Summary
Seattle Children's Hospital is a medical facility located in Seattle, Washington. This center is recognized for care of Leukemia, Brain Tumor, Tumors, Neuroblastoma, Recurrence and other specialties. Seattle Children's Hospital is involved with conducting 1,025 clinical trials across 1,146 conditions. There are 77 research doctors associated with this hospital, such as Sarah Leary, MD, Navin Pinto, MD, Simon Horslen, MD, and Evelyn Hsu, MD.Area of expertise
1Leukemia
Global LeaderCD19 positive
CD22 positive
Stage IV
2Brain Tumor
Global LeaderStage IV
Stage I
Stage II
Top PIs
Sarah Leary, MDSeattle Children's Hospital7 years of reported clinical research
Expert in Brain Tumor
Expert in Tumors
74 reported clinical trials
129 drugs studied
Navin Pinto, MDSeattle Children's Hospital1 year of reported clinical research
Expert in Neuroblastoma
Studies Osteosarcoma
22 reported clinical trials
32 drugs studied
Simon Horslen, MDUPMC Children's Hospital of Pittsburgh16 years of reported clinical research
Studies Liver Disease
Studies Cholestasis
9 reported clinical trials
8 drugs studied
Evelyn Hsu, MDSeattle Children's Hospital2 years of reported clinical research
Studies Liver Disease
Studies Biliary Atresia
8 reported clinical trials
9 drugs studied
Clinical Trials running at Seattle Children's Hospital
Brain Tumor
Diffuse Intrinsic Pontine Glioma
Osteosarcoma
Astrocytoma
Medulloblastoma
Tumors
Lymphoma
Recurrence
Germ Cell Tumors
Cancer
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Selumetinib vs Carboplatin/Vincristine
for Brain Cancer
This phase III trial studies if selumetinib works just as well as the standard treatment with carboplatin/vincristine (CV) for subjects with NF1-associated low grade glioma (LGG), and to see if selumetinib is better than CV in improving vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low-grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether selumetinib works better in treating patients with NF1-associated low-grade glioma compared to standard therapy with carboplatin and vincristine.
Recruiting2 awards Phase 328 criteria
Selumetinib + Vinblastine
for Low-Grade Glioma
This phase III trial investigates the best dose of vinblastine in combination with selumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinib alone in treating children and young adults with low-grade glioma (a common type of brain cancer) that has come back after prior treatment (recurrent) or does not respond to therapy (progressive). Selumetinib is a drug that works by blocking a protein that lets tumor cells grow without stopping. Vinblastine blocks cell growth by stopping cell division and may kill cancer cells. Giving selumetinib in combination with vinblastine may work better than selumetinib alone in treating recurrent or progressive low-grade glioma.
Recruiting2 awards Phase 339 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Seattle Children's Hospital?
Seattle Children's Hospital is a medical facility located in Seattle, Washington. This center is recognized for care of Leukemia, Brain Tumor, Tumors, Neuroblastoma, Recurrence and other specialties. Seattle Children's Hospital is involved with conducting 1,025 clinical trials across 1,146 conditions. There are 77 research doctors associated with this hospital, such as Sarah Leary, MD, Navin Pinto, MD, Simon Horslen, MD, and Evelyn Hsu, MD.
Where is Seattle Children's Hospital located?
**Seattle Children's Hospital**
- **Address:** 4800 Sand Point Way NE, Seattle, WA 98105.
- **Directions:** From the Fred Hutchinson Cancer Research Center, take WA-520 West over the Evergreen Point Floating Bridge. Then, merge right onto Montlake Boulevard E, leading directly to NE 45th Street.
Who should I call to ask about financial aid or insurance network?
Seattle Children's Hospital offers comprehensive financial assistance and insurance support. Financial counselors are available at (206) 987-3333 to assist with Medicaid applications, insurance options, payment plans, and the Seattle Children's Financial Assistance Program. The Insurance Authorization Team manages pre-authorization requests, with specific plans like Kaiser Health Foundation Plan of Washington and TriCare requiring pre-authorization. Financial assistance documents are accessible in multiple languages, including English, Spanish, Russian, Vietnamese, and Somali, with a 25% discount available for uninsured patients not qualifying for full or partial assistance.
What insurance does Seattle Children's Hospital accept?
Seattle Children's Hospital accepts a wide range of insurance plans, including but not limited to Aetna, Alaska Medicaid, Amerigroup Washington Apple Health plans, and Blue Cross Blue Shield of Montana. It's important to verify the specifics of your insurance plan, as referrals and approved authorizations may be required before care can be provided. For mental health services coverage, please consult the hospital's mental health insurance coverage page for detailed information.
What awards or recognition has Seattle Children's Hospital received?
Seattle Children's Hospital has been gifted $50 million to bolster leukemia research and fund clinical trials. The hospital also provides several intramural funding programs, including the Research Platform Award, designed to boost its ability to secure externally funded research.